Diagnosing Alopecias: Key Elements and Insights from Clinical Cases
AlopeciaHair loss is a common yet complex condition that presents a significant challenge for both patients and dermatologists alike. Accurate diagnosis and effective management often require a meticulous and nuanced approach that enables the physician to discern subtle clues that distinguish between various etiologic forms of alopecia. At the 2025 Orlando Dermatology, Aesthetic, and Surgical Conference, …
Alopecia
JDD Buzz Series | Sunscreens: Mechanisms and Safety in Depth
sunscreen[vc_row][vc_column][vc_column_text css=""]Despite decades of educational efforts, there is growing public skepticism over sunscreen’s safety and efficacy. Researchers from Chicago sought to synthesize the current scientific understanding of sunscreen in order to help dermatology clinicians address concerns. The findings are published in the February Journal of Drugs in Dermatology. I intervie …
sunscreen
First-Timer at ODAC? Here’s Why You’ll Want to Come Back Every Year
ODAC Dermatology ConferenceA First-Time Attendee’s Experience at ODAC 2025: A Conference Worth Attending As a first-time attendee at the 2025 ODAC Dermatology Conference, I was beyond impressed with my experience. From the expertly curated sessions to the invaluable networking opportunities, ODAC delivered an immersive and engaging educational experience. If you are considering attending in the future, let me assure you� …
ODAC Dermatology Conference
Building Bridges: Purposeful Networking, Collaboration, and Career Growth with Industry Relationships
Working with industry is a common career goal of dermatologists, whether it’s by serving on an advisory board, obtaining a grant, or collaborating in another way. So how does a dermatologist land these industry opportunities? Watch as Dr. Adam Friedman, co-chair of the ODAC Dermatology Conference, outlines how to build bridges with industry partners. Find out why it’s important to understand t …
JDD February 2025 Editor’s Picks
JDDThe February 2025 issue of the Journal of Drugs in Dermatology brings a fresh wave of clinical insights and innovative research to the dermatology community. This edition highlights new perspectives on minoxidil adherence, groundbreaking findings in keloid and hypertrophic scar risk factors, and expert consensus on deucravacitinib for plaque psoriasis. Readers will also discover updates on non- …
JDD